Status:
UNKNOWN
Evaluation of the Best Treatment in Terms of Quality of Life for Patients Having a Brain Metastasis
Lead Sponsor:
University Hospital, Caen
Conditions:
Quality of Life
Brain Metastases
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Main Goal : evaluation of quality of life for patient having a brain metastasis and allowed to have either surgery and radiosurgery of the surgical site or only hypofractionned radiosurgery on the les...
Detailed Description
A patient with a brain metastasis may have the choice between surgery and focal radiosurgery of the surgical site and only hypofractionned radiosurgery on the lesion. No previous study has focused on...
Eligibility Criteria
Inclusion
- eligible for both treatments options OMS status \<3 primary cancer with no evolution brain metastasis \< 3cm ou giving symtoms patient with informed consent patient affilated to french social security
Exclusion
- OMS \> 3 More than 3 brain metastasis brain metastasis already treated with hypofractionned radiosurgery
Key Trial Info
Start Date :
March 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04358666
Start Date
March 6 2020
End Date
March 30 2024
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU CAEN
Caen, France, 14000